Daiwa Securities Group Inc. Adma Biologics, Inc. Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 858 shares of ADMA stock, worth $12,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
858
Previous 780
10.0%
Holding current value
$12,475
Previous $15,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
400Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$311 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$271 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$186 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...